UBS Group’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
– Sell
-13,800
Closed -$1.26M – 11035
2025
Q2
$1.26M Buy
+13,800
New +$1.33M ﹤0.01% 5239
2025
Q1
– Sell
-12,700
Closed -$1.34M – 10784
2024
Q4
$1.34M Hold
12,700
– – ﹤0.01% 5086
2024
Q3
$1.37M Sell
12,700
-3,000
-19% -$327K ﹤0.01% 4351
2024
Q2
$1.7M Sell
15,700
-4,600
-23% -$542K ﹤0.01% 3935
2024
Q1
$2.68M Buy
+20,300
New +$2.54M ﹤0.01% 3645
2021
Q2
– Sell
-8,858
Closed -$1.38M – 9894
2021
Q1
$1.38M Hold
8,858
– – ﹤0.01% 3928
2020
Q4
$1.32M Sell
8,858
-6,592
-43% -$931K ﹤0.01% 3781
2020
Q3
$2.04M Hold
15,450
– – ﹤0.01% 3015
2020
Q2
$1.79M Buy
15,450
+8,034
+108% +$926K ﹤0.01% 2982
2020
Q1
$728K Hold
7,416
– – ﹤0.01% 3635
2019
Q4
$1.08M Buy
+7,416
New +$1.02M ﹤0.01% 4139
2019
Q3
– Sell
-2,781
Closed -$318K – 8304
2019
Q2
$318K Sell
2,781
-22,866
-89% -$2.68M ﹤0.01% 4614
2019
Q1
$3.18M Buy
+25,647
New +$2.91M ﹤0.01% 2582
2018
Q1
– Sell
-2,266
Closed -$265K – 8220
2017
Q4
$265K Buy
+2,266
New +$256K ﹤0.01% 4728
2017
Q3
– Sell
-86,314
Closed -$10.8M – 8044
2017
Q2
$10.8M Buy
+86,314
New +$10.2M 0.01% 1474
2017
Q1
– Sell
-11,611
Closed -$1.16M – 8036
2016
Q4
$1.16M Buy
+11,611
New +$1.24M ﹤0.01% 3421
2016
Q2
– Sell
-11,351
Closed -$1.18M – 8013
2016
Q1
$1.18M Buy
11,351
+11,248
+10,920% +$1.09M ﹤0.01% 3115
2015
Q4
$10K Hold
103
– – ﹤0.01% 7290
2015
Q3
$9K Hold
103
– – ﹤0.01% 7353
2015
Q2
$11K Hold
103
– – ﹤0.01% 7404
2015
Q1
$12K Buy
+103
New +$11.8K ﹤0.01% 7507

Other funds holding ZBH

UBS Group's ZBH Position: Q3 2026 in Review

UBS Group reduced its Zimmer Biomet (ZBH) stake by 59% in Q3 2026, selling an estimated $155M and leaving 1,127,503 shares worth $100M. The position accounts for 0.01% of the portfolio, ranked #1091.

UBS Group first reported a position in ZBH in Q4 2014 and has held it in 48 quarters since. The position peaked at $237M in Q2 2026. 931 funds tracked by Wall St. Rank hold ZBH as of Q3 2026.

  • UBS Group held 1,127,503 shares of Zimmer Biomet worth $100M as of Q3 2026.
  • UBS Group sold 1,631,112 Zimmer Biomet shares in Q3 2026, an estimated $155M.
  • Zimmer Biomet made up 0.01% of UBS Group's portfolio in Q3 2026, its #1091 holding.
  • UBS Group first reported a position in Zimmer Biomet in Q4 2014 and has held it in 48 quarters since.
  • UBS Group's Zimmer Biomet position peaked at $237M in Q2 2026.
  • 931 funds tracked by Wall St. Rank held Zimmer Biomet as of Q3 2026.

Based on UBS Group's 13F filing for Q3 2026, filed 10 Nov 2026.